Resumen
The invention relates to in vitro methods for determining the prognosis of a subject diagnosed with pulmonary adenocarcinoma. In particular, the invention relates to a gene signature, the expression of which correlates with the prognosis of a subject diagnosed with pulmonary adenocarcinoma.